Drug Trial Radar · NCT06521931
A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients
Last checked: Nov 19, 2026Latest source record: Mar 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Dec 6, 2023
Primary completion
Jan 13, 2025
Study completion Jan 13, 2025
Sponsor
- Lead sponsor
- Chongqing Peg-Bio Biopharm Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of this clinical trial is to assess the safety and tolerability of PN20 in adult patients with chemotherapy-induced thrombocytopenia (CID). The main questions it aims to answer are: * Is PN20 safe in these patients? * Could these patients potentially benefit from PN20 prevention? Participants will * Receive subcutaneous injections of PN20 according to weight on the first day of chemotherapy cycle, within 1 hour before the administration of chemotherapy drugs, * Visit the clinic on Day 1 (D1), D2, D3, D4, D5, D8, D11, D13, D15 and D21 for assessment.
Conditions
- Thrombocytopenia
Interventions
PN20Drug
Three dose cohorts: 0.2, 0.5 and 0.75 mg/kg, subcutaneous injections, on Day 1 of chemotherapy cycle before the administration of chemotherapy drugs
Primary outcomes
What the sponsor says the trial is designed to measure.
- AE in single-dose phaseTime frame: Day 1-21 of Cycle 1 (each cycle is 21 days)
- The proportion of patients with PLT ≥ 100×10^9/L in multiple-dose phaseTime frame: Day 21 of Cycle 2 (each cycle is 21 days)
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Affiliated Hospital of Hebei University
Baoding, Hebei, China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Henan Cancer Hospital
Zhengzhou, Henan, China
Yiyang Central Hospital
Yiyang, Hunan, China
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Affiliated Hospital of Southwest Medical University
Luzhou, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.